Pfizer won’t move to Phase 3 trial of 2x-daily weight-loss drug, stock off 4%

<p>Pfizer won’t move to Phase 3 trial of 2x-daily weight-loss drug, stock off 4% Read Full Story</p>
<p>The post <a href="https://forextv.com/market-news/pfizer-wont-move-to-phase-3-trial-of-2x-daily-weight-loss-drug-stock-off-4/">Pfizer won’t move to Phase 3 trial of 2x-daily weight-loss drug, stock off 4%</a> appeared first on <a href="https://forextv.com">ForexTV</a>.</p>